Company Performance Metrics
INEX Innovate is one of Asia’s fastest growing medical technology developers and medical laboratory operators. Spun out from the National University of Singapore (NUS), INEX is Asia’s first Women’s health technology group. Founded by maternal-fetal medicine specialists, INEX focuses on developing and commercializing molecular diagnostic
technologies in the areas of fetal health and women’s oncology.
INEX has a broad commercial portfolio of validated tests in prenatal health, ovarian and breast cancers along with more than 48 key patents, additionally, through its wholly owned subsidiary iGene Laboratory, INEX operates a College of American Pathologist (CAP) accredited Next Generation Sequencing (NGS) laboratory that provides diagnostic testing, contract research (CRO) and COVID-19 testing services.
The company has been recognised globally with a number of accolades and awards including from Frost & Sullivan, the World Intellectual Property Organisation (WIPO), The Straits Times – Singapore’s Fastest Growing Companies and the Financial Times ranking of 500 of Asia Pacific’s Fastest Growing Companies.
For more information please visit: www.inex.sg
